Skip to main content

Peer Review reports

From: Inhibition of SMAD3 effectively reduces ADAMTS-5 expression in the early stages of osteoarthritis

Original Submission
10 May 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
27 Jun 2022 Reviewed Reviewer Report
8 Jul 2022 Reviewed Reviewer Report
23 Jul 2022 Author responded Author comments - Weishan Wang
Resubmission - Version 5
23 Jul 2022 Submitted Manuscript version 5
26 Jul 2022 Author responded Author comments - Weishan Wang
Resubmission - Version 6
26 Jul 2022 Submitted Manuscript version 6
30 Jul 2022 Author responded Author comments - Weishan Wang
Resubmission - Version 7
30 Jul 2022 Submitted Manuscript version 7
1 Aug 2022 Author responded Author comments - Weishan Wang
Resubmission - Version 8
1 Aug 2022 Submitted Manuscript version 8
5 Aug 2022 Author responded Author comments - Weishan Wang
Resubmission - Version 9
5 Aug 2022 Submitted Manuscript version 9
12 Aug 2022 Reviewed Reviewer Report
30 Aug 2022 Reviewed Reviewer Report
12 Sep 2022 Author responded Author comments - Weishan Wang
Resubmission - Version 10
12 Sep 2022 Submitted Manuscript version 10
17 Sep 2022 Author responded Author comments - Weishan Wang
Resubmission - Version 11
17 Sep 2022 Submitted Manuscript version 11
5 Oct 2022 Reviewed Reviewer Report
30 Oct 2022 Author responded Author comments - Weishan Wang
Resubmission - Version 12
30 Oct 2022 Submitted Manuscript version 12
3 Nov 2022 Reviewed Reviewer Report
Resubmission - Version 13
Submitted Manuscript version 13
Publishing
4 Nov 2022 Editorially accepted
17 Feb 2023 Article published 10.1186/s12891-022-05949-8

You can find further information about peer review here.

Back to article page